| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.97▼ | 3.98▼ | 3.98▼ | 3.99▼ | 4.29▼ |
| MA10 | 4.05▼ | 4.05▼ | 4.10▼ | 4.86▼ | 2.37▲ |
| MA20 | 4.28▼ | 4.35▼ | 4.56▼ | 5.20▼ | 1.54▲ |
| MA50 | 5.39▼ | 5.64▼ | 4.64▼ | 2.35▲ | 1.16▲ |
| MA100 | 3.80▲ | 3.02▲ | 2.54▲ | 1.55▲ | 1.22▲ |
| MA200 | 2.12▲ | 1.80▲ | 1.61▲ | 1.20▲ | 1.23▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.022▲ | -0.028▼ | -0.120▼ | -0.431▼ | 0.484▲ |
| RSI | 32.322▼ | 31.799▼ | 33.177▼ | 48.651▼ | 62.444▲ |
| STOCH | 20.257 | 16.277▼ | 9.688▼ | 6.110▼ | 58.456 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -98.329▼ | -49.931 |
| CCI | -143.868▼ | -107.886▼ | -98.475 | -83.729 | 68.052 |
|
Friday, October 02, 2026 01:36 PM
Neurosense Therapeutics (NRSN) said late Friday it received a letter from the Nasdaq Listing Qualifications Department on Thursday stating that it has not regained compliance with the Nasdaq listing ...
|
|
Friday, October 02, 2026 05:30 AM
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the "Company"), a late-stage clinical biotechnology company focused on developing disease-modifying treatments for neurodegenerative ...
|
|
Wednesday, September 30, 2026 05:00 PM
Detailed price information for Neurosense Therapeutics Ltd (NRSN-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/10/26 | 3.88 | 3.88 | 3.88 | 3.88 | 2,815 |
| 06/10/26 | 4.03 | 4.33 | 3.94 | 4.07 | 17,784 |
| 05/10/26 | 4.06 | 4.54 | 3.96 | 4.03 | 12,245 |
| 02/10/26 | 3.97 | 4.01 | 3.82 | 3.935 | 24,230 |
| 01/10/26 | 4.37 | 4.37 | 3.8274 | 4.05 | 51,913 |
| 30/09/26 | 4.71 | 4.7425 | 4.00 | 4.43 | 40,386 |
| 29/09/26 | 5.04 | 5.54 | 4.355 | 4.78 | 35,864 |
| 28/09/26 | 6.91 | 7.15 | 4.925 | 5.10 | 61,785 |
| 25/09/26 | 7.18 | 7.18 | 6.7325 | 6.95 | 8,674 |
| 24/09/26 | 7.20 | 7.40 | 6.925 | 7.40 | 8,879 |
|
|
||||
|
|
||||
|
|